GSK3B and early-onset autosomal dominant Alzheimer disease: Activated Akt inhibits pro-apoptotic factors such as Bad and glycogen synthase kinase 3 beta (GSK‐3β), which is implicated in tau hyperphosphorylation, a hallmark of Alzheimer’s disease (AD).